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Abstract: Background and aims: The primary aim of the present review was to summarize the findings of genetic studies conducted on 
problem and pathological gambling. Method: Literature searches were conducted using PubMed, Medline and the HuGE Navigator da-
tabases using the keywords ‘gambling’ and ‘genetic*’. Results: The literature searches identified 21 empirical studies that had analyzed 
data from eight independent samples. Empirical research utilizing twin data accounted for eight of the studies, while gene association 
data were presented in 13 studies (including one genome wide-association study [GWAS] study). Twin studies emphasized the signifi-
cant role of genetic and individual environmental factors in problem and pathological gambling. Gene association studies primarily re-
ported the involvement of the dopaminergic and serotonergic systems. Discussion: Despite the relatively low number of genetic studies, 
the data clearly indicated the genetic vulnerability of problem and pathological gambling. Studies to date have mainly investigated and 
verified the role of factors reported to be important in other types of addiction, and it is suggested that pathological gambling should be 
included as a subtype of ‘Reward Deficiency Syndrome’ (RDS). It is concluded that future research should attempt to identify possible 
gambling specific susceptibility factors.  
Keywords: Problem/pathological gambling, gambling addiction, behavioral addiction, systematic review, twin studies, genetic association 
studies, reward deficiency syndrome. 
INTRODUCTION 
 Pathological gambling is a chronic, progressive disorder that is 
often associated with serious financial consequences, loss of em-
ployment, substance use, health problems, relationship problems, 
and criminalization [1, 2]. Although pathological gambling is still 
classified among impulse control disorders, it has now been classi-
fied as an addiction disorder in the new DSM-V. With this change, 
gambling disorder is the first behavioral addiction [3, 4] to be offi-
cially considered an addictive disorder. As with all addictions, 
pathological gambling disorder is a multi-causal behavior. In addi-
tion to the relatively widely researched social and psychological 
etiological factors, more recent research has emphasized the impor-
tance of neurobiological factors. Despite the increase in neurobi-
ological research, the number of studies examining the genetic as-
pects of pathological gambling is low compared to chemical addic-
tions [5].  
 There are now well-defined methods available for the analysis 
of genetic factors. Both twin and adoption studies enable the analy-
sis of the individual and epistatic effects of genetic factors and their 
interactions with environmental factors. Furthermore, molecular 
genetic studies do not typically allow for the estimation of the ge-
netic effect in general, but for the identification of one or more 
specific genetic factors. The aim of the present paper is to provide a 
systematic review and summary of all the empirical research con-
cerning the genetic background of problem and pathological gam-
bling.  
METHOD
Inclusion and Exclusion Criteria 
 The objective of the present study was to review all the empiri-
cal literature concerning the genetic aspects of problem and  
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pathological gambling that have been published in the English lan-
guage. Problem gambling is considered as a less severe form of 
gambling activity when the diagnosis of pathological gambling 
cannot be confirmed, although a few symptoms of the disorder are 
already present. As most of the studies deals with problem gam-
bling as well as pathological gambling, it was decided to include 
both populations in the review. All studies published in English in a 
scientific journal and that reported empirical results concerning the 
genetic study of gambling were included in the analysis. Literature 
searches were carried out in September 2012 with the combination 
of keywords ‘gambling’ and ‘genetic*’ on PubMed and Medline 
databases. No other filter was applied. The search was also carried 
out using the HuGE Navigator (http://www.hugenavigator.net)
database. As a result of the literature search, 159 papers were found 
on PubMed, 146 on Medline and 32 on the HuGE database. After 
the exclusion of duplicates, a total of 185 papers remained for fur-
ther review and analysis.  
Filtering Method 
 Papers containing irrelevant content to the aims of the present 
study (n=147) were excluded from the analytic review. In these 147 
papers, the keyword ‘gambling’ indicated only an indirect relation 
and did not actually address gambling. Four other studies were 
excluded due to linguistic reasons (i.e., the papers were not pub-
lished in English). Since the primary objective of the present study 
was to create an overview of all empirical data, a further nine re-
view studies that did not contain any new empirical data were also 
excluded. One further study [6] was excluded, since it did not re-
veal any data on the risk for pathological gambling, and only exam-
ined the extent to which the genetic and environmental risk for 
gambling could be explained by the risk for alcohol dependence. 
Three other studies [7-9] were also excluded for the reason that 
although they had some relevance to the topic, they did not examine 
problem gambling behavior per se but assessed neuropsychological 
tasks with a gambling component on general population partici-
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pants. This filtering process left 21 studies remaining for inclusion 
and further review.  
RESULTS
Datasets Utilized 
 The 21 identified empirical studies analyzed data from eight 
independent samples. Five twin studies were based on the Vietnam 
Era Twin Registry (VETR) data, while an additional three datasets 
were used in three other published studies. Among the studies ex-
amining specific genetic factors, five studies published by a Span-
ish research group analyzed the same dataset, while the four studies 
published by Comings and his colleagues [10-13] also used various 
subsamples of one original dataset. Two Brazilian studies also used 
an identical dataset of 140 participants [14, 15]. The one remaining 
study utilized its own distinct dataset. 
Types of Data Collected 
 The research papers included in the present review broadly 
comprised two different types of genetic investigations. The first set 
of research papers (n=8) utilized data from twin studies carried out 
among four different datasets. These studies utilized samples origi-
nating from twin pairs and estimated the effect size of genetic and 
environmental factors, and their interaction. However, these data 
are unsuitable in identifying specific genetic factors. The second set 
of studies (n=13) examined genetic associations in order to analyze 
the effects of one or more specific genetic factors. Among these 13 
papers, one reported a specific type of genetic association study 
using over 2 million variable markers fairly evenly distributed 
throughout the entire genome (i.e., a genome wide-association 
study; GWAS). 
Place and Date of Research Study Publication 
 Five studies were published in the 1990s (the earliest one being 
published in 1996) with the remaining 16 studies all published since 
2000. More than half of the studies (n=11) were published by re-
search teams from the United States. Five studies came from re-
search teams in Spain, two from Australia, two from Brazil, and 
one from Canada.  
Results of Twin Studies 
Samples of Twin Studies 
 The published twin studies were carried out on four independ-
ent datasets. Of these, the Add Health study [16] is the only one that 
represents the general population by including children from ele-
mentary and secondary schools. Data for the study were first col-
lected in 1994 and 1995. During this time, approximately 90,000 
young people were involved in the study. In the first data collection 
period, a subsample of people living together was created with the 
participation of 20,740 adolescents and 17,000 parents/primary 
caregivers. The second round of data collection took place in 1996 
and researchers were able to contact 14,738 young individuals suc-
cessfully. The third round of data collection was carried out during 
2001 and 2002 comprising 15,197 people. This sample contained 
324 monozygotic (MZ) and 278 dizygotic (DZ) twins [16].  
 Five studies have been published utilizing data from the Viet-
nam Era Twin Registry. The entire sample consisted of several 
thousands of male twins who were engaged in military service dur-
ing the Vietnam War (1964-1975). This dataset was originally a 
part of a military records database, but throughout the years it has 
also become a source for genetic and epidemiologic studies. Differ-
ent studies utilized different subsamples of this dataset. In the Aus-
tralian Twin Registry-Cohort, twins were recruited to register by 
calls from the Australian National Health and Medical Research 
Council and through the school system between 1980 and 1982. In 
total, 4,268 pairs of twins (i.e., 8536 people) were born and regis-
tered in Australia between 1964 and 1971. The first wave of data  
collection took place between 1989 and 1992, while the second 
wave was carried out between 1996 and 2000. During the second 
wave of the study 4764 people participated. In addition to telephone 
interviews, respondents also completed questionnaires received by 
mail [17]. One study carrying out a genetic association study (to be 
discussed later), also used this dataset [18].
 Blanco et al. [19] collected data from 43,799 people using an 
online survey. The survey was carried out between July 2005 and 
April 2010. The online tool consisted of personality questionnaires 
and measures for the assessment of psychopathological data and 
substance use. The questionnaire was available for all 43,799 to 
complete. Ultimately, the sample comprised 414 monozygotic and 
159 dizygotic twin pairs [20]. 
Methods Used in Twin Research Studies to Assess Problem and 
Pathological Gambling 
 The studies relating to the Vietnam Era Twin Registry contained 
problem and pathological gamblers with a diagnosis based on the 
DSM-III-R or DSM-IV classification system carried out by tele-
phone interview [21-25]. For participants of the Australian Twin 
Registry Cohort, the NODS (National Opinion Research Center 
DSM-IV Screen for Gambling Problems) was applied to assess 
gambling-related problems, and is a tool that utilizes the DSM-IV 
criteria for pathological gambling [26]. On the Add Health sample, 
Beaver et al. [16] evaluated gambling-related problems using eight 
individually developed interview questions. The appropriateness of 
these applied questions was confirmed afterwards by psychometric 
analysis. Blanco et al. [19] identified pathological gamblers using 
the DSM-IV diagnostic criteria. The criteria were initially assessed 
among those people who previously reported gambling activity at 
least 24 times in their lifetime. However, fully syndromal DSM-IV 
PG was rare in this sample, therefore they created a four-category 
variable termed “symptoms of PG” Categories were: (1) 0-24 life-
time episodes of gambling; (2) >25 lifetime episodes of gambling 
and zero endorsed PG criteria; (3) >25 lifetime episodes of gam-
bling and one PG criterion endorsed; (4) >25 lifetime episodes of 
gambling and two or more PG criteria endorsed.  
Summary of the Results of Twin Studies 
 Based on the results of twin studies, findings indicate that ge-
netic factors contribute significantly to the formation of problem 
and pathological gambling (see Table 1) irrespective of the defini-
tion and tools assessed in the context of problem and pathological 
gambling. A consistent result of twin studies is that shared envi-
ronmental factors (e.g., family events, shared friends, shared school 
experiences, etc.) do not contribute significantly to the formation of 
gambling problems. However, one exception is the study by Beaver 
et al. [16] that reported genetic factors failed to explain the variance 
in gambling for females. Shared environment, however, accounted 
for 45% of the variance and the remaining 55% was attributable to 
non-shared environmental factors. Alternatively, Slutske et al. [26] 
highlighted the importance of shared environmental factors (taking 
the confidence interval (CI= 0,0-4,1] into account), so environ-
mental factors should not be completely ruled out. Based on studies 
focusing on comorbid disorders, it appears that prob-
lem/pathological gambling and other psychiatric disorders (e.g., 
major depression [22]) have a partially shared genetic background. 
According to the findings of Blanco et al. [19], there is only a slight 
difference in the frequency of gambling between MZ and DZ twins 
with a moderately lower frequency in the DZ group. Familial re-
semblance for frequency of gambling resulted both from substantial 
common environmental effects and (to a slightly lesser degree) 
from genetic effects. Results of this study show that regarding 
pathological gambling-related symptoms, the proportion of genetic 
to individual-specific environmental influence was the same in men 
and women.  
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Table 1. Summary of the findings of twin studies 
Study Sample PG prevalence 
Variance 
explained by 
genetic factors 
Variance explained 
by shared 
environment 
Variance 
explained by 
non-shared 
environment 
Comorbidity 
Slutske et 
al. (2001) 
VETR1
(N=7869) 
Pathological gambler: 
1.4 % 
Subclinical pathological
gambler: 6.4% 
Problem gambler: 7.8%
50% 0% 50% 
Genetic and non-shared 
environmental factors 
found in the background 
of PG and antisocial 
personality disorder 
partly overlap.  
Potenza et 
al. (2005) 
VETR1
(N=7869) 
Pathological gambler: 
1.4% 
66% 0% 34% 
PG and major depression
have 34% shared genetic 
background. 
Scherrer et 
al. (2005) 
VETR1
(N=1687) 
Pathological gambler: 
3.1% 
Problem gambler: 16% 
no exact 
percentage no exact percentage 
no exact 
percentage Has not been studied 
Xian et al.
(2007) 
VETR1
(N=8169 in 
1992; 3350 in 
2002) 
8.2% of the two 
samples met at least one
or more DSM-III-R 
patholgical gambling 
criteria one year prior 
the study. 
48.9% (1992) 
57.5% (2002) 
0% 
51.1% (1992) 
42.6% (2002) 
Has not been studied 
Beaver et 
al. (2010) 
Add Health2
(N=602) 
No data available 
72% (total sample)
85% (only male) 
0% (only female) 
0% (total sample) 
0% (only male) 
45% (only female) 
28% (total 
sample) 
15%(only male) 
55% (only 
female) 
Has not been studied 
Slutske et 
al. (2010) 
ATRC3
(N=4764) 
Pathological gambler:  
 2.2% (total sample);  
 3.4% (only male); 
 1.2% (only female);  
Problem gambler:  
 1.7% (total sample);  
 2.4% (only male);  
 1.1% (only female) 
49.2% (total 
sample) 
48.5% (only male)
51.8% (only 
female) 
0% 
50.7% (total 
sample) 
51.4 (only male)
48.2% (only 
female) 
Has not been studied 
Giddens et 
al. (2011) 
VETR1
(N=7869) 
Pathological gambler: 
1.4% 
65% no exact percentage 36% 
PG and generalized 
anxiety disorder have 
29%; PG and panic 
disorder have 7% shared 
genetic background  
Blanco et 
al. (2012) 
N= 43799 Disordered gambling
a:
0.9% 
32%b 42% no exact 
percentage  
Environmental experi-
ences that increased risk 
for disordered gambling 
also increased risk for 
lifetime major depres-
sion, nicotine depend-
ence and alcohol 
consumption, and 
modestly decreased the 
level of caffeine con-
sumption. 1 VETR: Vietnam Era Twin Registry 
2AddHealth: National Longitudinal Study of Adolescent Health 
3ATRC: Australian Twin Registry Cohort 
a Disordered gambling was defined as a four-category variable based on the number of lifetime PG episodes and endorsed PG criteria
b Familial resemblance for number of times gambled in twin and sibling pairs 
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Table 2. Brief summary of the findings of gene association studies. 
Study Sample System Gene Result
Comings et al.
(1996) 
N=171 PG
714 control 
Dopaminergic ANKK1 TaqIA, DRD3 Msc I 
PG: 50.9% carries the A1 allele (p<0.001) 
Control: 25.9% 
Pérez de Castro et al.
(1997) 
N=68 PG, 
68 matched control 
Dopaminergic DRD4 48 bp repeat polimorphism PG: D4(7)/D4(7) detected only in this 
group 
Comings et al.
(1997) 
N1=127 PG, 124 
control 
N2= 186 PG, 138 
control 
Dopaminergic DRD1 Dde I, ANKK1 Taq I A1/A2 
PG: 14.1% homozygote for DRD1 Dde I 
allele (p= 0.020); DRD2 TaqI 12 group was
carried by 45.7% (p<0.001); DRD1 11/ 22 
and ANKK1 TaqI 12 genotype was carried 
by 23.3%  
Pérez de Castro et al.
(1999) 
N=68 PG  
68 matched control 
Serotonergic 5-HTTLPR PG: short allele version has significantly higher prevalence in male (p=0.02)
Comings et al.
(1999) 
N= 165 PG, 737 
control 
Dopaminergic DRD4 PG: significant association with DRD4 
5,6,7,8 repeat alleles (p<0.001)
Ibanez et al. (2000) 
N=68 PG  
68 matched control 
Catecholaminerg MAO/A, MAO/B 
Most severe male PG: the distribution of 
MAO/A alleles differs significantly from 
controls (p<0.05)
Comings et al.
(2001) 
N=139 PG 
139 matched control 
Dopaminergic 
Serotonergic 
GABAergic 
Other 
DRD1,DRD2, DRD3, DRD4, 
DRD5, DAT1, SLC6A4, HTR1A, 
HTR1DB, HTR2A, HTR2C, 
TDO2 , TPH, GABRA1, 
GABRA3, GABRB1, GABRB3, 
NMDAR1, CHRNA4 , AR, INFG,
PS1, CRH 
PG: significant association with DRD2 
(p<0.001), DRD4 (p<0.001), 
DAT1(p<0.05) , ADRA2C (p<0.001),  
TPH (0.0005) and TDO2 (p<0.05) genes 
Ibanez et al. (2001) N= 69 PG Dopaminergic DRD2  
PG: DRD2 C4 allele has significantly 
higher prevalence in lifetime comorbid 
disorder (p<0.003) 
Pérez de Castro et al.
(2002) 
N=68 PG 
68 matched control 
Serotonergic MAO-A (MAOA-uVNTR), 5-
HTTLPR 
PG:MAOA-uVNTR 3 copy allele 
prevalence significantly higher (p<0.043) 
less efficient transcript alleles of MAO/A 
and 5-HTTLPR genes have significantly 
higher prevalence in more severe male PG 
group (p<0.001) 
Lobo et al. (2007) N= 140 PG + 140 
siblings 
Dopaminergic DRD1, DRD2, DRD3,DRD4, 
DRD5, SLC6A3 
PG: significant association with DRD1 800
T/C allele (p<0.03) 
Lobo et al. (2010) N=242 NPG Dopaminergic DRD1, DRD2, DRD3 Tendency of lower PGSI scores in 
TaqIA/rs1800497 polimorphism (p=0.10)
Wilson et al. (2012) N=140 (discordant 
sib-pairs) 
Serotonergic 
44bp, 1B, G861C substitution 
polymorphism (5HT-1B G861C), 
2A, T102C exon 1 substitution
PG: significant association was found with 
the C allele and the C/C genotype of 5HT-
2A T102C (p< 0.03)
Lind et al. (2012) 
N= 4764 (Australian 
Twin Registry 
Cohort)
Genome wide 
association study 
2,381,914 single nucleotide poly-
morphisms (SNP)  
PG: secondary case-control analysis sho-
wed that three SNPs [chromosome 9 
(rs1106076 and rs12305135 near VLDLR) 
and rs10812227 near FZD10 on chromo-
some 12)] have significant associations 
with the lifetime DSM-IV diagnosis of the 
South Oaks Gambling Screen (SOGS (35) 
diagnosis.
N1: Nr of participants in DRD1 allele analysis  
N2: Nr of participants in DRD2 allele analysis  
PG: Pathological gambler 
NPG: Non-pathological gambler 
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RESULTS OF THE GENE ASSOCIATION ANALYSES 
Samples of the Candidate Gene Studies 
 Eight of the 13 studies analyzed datasets consisting of patho-
logical/problem gamblers and adjusted control groups (see Table 2).
One study analyzed data from a general population survey [27]. 
Two studies scanned pairs of siblings where one of them was a 
problem/pathological gambler [14, 15], and one study investigated 
gamblers who were participating in a special therapeutic program 
[28]. For the study examining the entire genome, Lind et al. [18] 
relied on the Australian Twin Registry-Cohort (discussed above in 
the section on twin study samples).  
Genetic Factors Studied 
 Given that the brain reward system is primarily associated with 
dopaminergic neurotransmission, while impaired behavioral inhibi-
tion and impulse control disorder are linked to the serotonergic 
system [29], it is plausible that the identified studies investigated 
the polymorphisms of genes linked to these two systems, as well as 
MAO (monoamine oxidase), that also plays a crucial role in the 
metabolism of serotonin and dopamine.  
Summary of Genetic Findings 
 Results of six studies [10, 11, 13, 14, 27, 28] show a significant 
association between the dopamine D2 receptor gene (DRD2) and 
pathological gambling. According to these results, the TaqIA poly-
morphism of the ANKK1 gene (previously believed to be located 
within the neighboring DRD2 gene [30]) might have an important 
role in this association. The results of Ibanez et al. [28] suggest that 
C4 allele of DRD2 TG microsatellite polymorphism in intron 2 is 
associated with the severity of pathological gambling and related 
lifetime comorbid disorders. Contrary to this, Lobo et al. [27] ob-
served that the ANKK1 TaqIA (rs1800497) polymorphism was 
associated with lower risk of pathological gambling. Homozygote 
DdeI and 800T/C alleles of DRD1 also seem to be associated with 
pathological gambling [10, 14] and comorbid alcohol dependence 
[29]. Three studies show that long alleles (5 to 8 repeat) of the 
DRD4 gene are associated with pathological gambling [11, 12, 31].  
 Impulsive behavior and impulse control disorder are also asso-
ciated with behavioral addictions, therefore specific studies also 
examined the role of the serotonergic system, which might have a 
role in pathological gambling-related impulsivity problems [29]. 
The role of the 5-HTTLPR polymorphism of the serotonin trans-
porter gene has been reported in two studies in male pathological 
gamblers [32, 33]. Additionally, Wilson et al. [15] found that 
pathological gambling was significantly associated with the C allele 
and C/C genotype of 5HT-2A T102C polymorphism. 
 Among the genes involved in serotonin metabolism, tryptophan 
hydroxylase (TPH) and tryptophan-2,3-dioxygenase (TDO2) were 
significantly associated with pathological gambling in the study of 
Comings et al. [11]. MAO-A has also been found to be associated 
with pathological gambling [33, 34] while MAO-B did not show 
any connection. 
Results of the GWAS Study 
 In the study by Lind et al. [18], 2,381,914 single nucleotide 
polymorphisms (SNP) from the entire genome were examined with 
methods of family-based association test, gene and pathway en-
richment analyses. None of the SNPs have reached the level of 
genome wide significance, however a p-value of less than 1x10-5 
was seen in case of 6 SNPs. These SNPs are located in three genes 
(i.e., MT1X, ATXN1 and VLDLR), and are assumed to play a role 
in pathological gambling. A secondary case-control analysis 
method showed that three SNPs [chromosome 9 (rs1106076 and 
rs12305135 near VLDLR) and rs10812227 near FZD10 on chro-
mosome 12]] have significant associations with the lifetime DSM-
IV diagnosis of pathological gambling and pathological gambling 
diagnosis of the South Oaks Gambling Screen (SOGS [35]). 
DISCUSSION 
 The combined findings of the twin studies presented in this 
review highlight the complex nature of the problem/pathological 
gambling phenotype. Based on the results of the studies identified, 
it is clear that genetic factors (in addition to environmental factors 
identified elsewhere in the gambling pathology literature) have an 
important role in the acquisition, development and maintenance of 
pathological gambling. Additionally, the results of twin study data 
indicate that the genetic background of gambling problems and 
comorbid disorders appear to partially overlap. Therefore, further 
studies are needed to confirm the associative relationships that 
might help further our understanding of the interaction of these 
environmental and genetic factors. However, there are also a num-
ber of contradictory findings. For instance, while Potenza et al. [22] 
found that pathological gambling and major depression shared 34% 
of their genetic variance, Blanco et al. [19] found a much weaker 
relationship between the two disorders. However, these contradic-
tory results might be explained by sample selection and differences 
in diagnostic criteria, bringing the authors to the assumption that the 
shared genetic variance between the two disorders may increase 
with the severity of gambling problems [19]. Further empirical 
examination of shared genetic factors of pathological gambling and 
comorbid disorders (e.g., depression) thus may help in identifying 
the common etiological factors. In this regard, focusing on the se-
verity of gambling problems would be especially useful, as it would 
further the understanding of the possible differences in the back-
ground of the initiation, development, and maintenance of gambling 
problems. Examination of adolescent samples may also be useful in 
this regard. 
 The primary finding of the combined genetic association studies 
indicate the involvement of dopaminergic and serotonergic systems. 
Such a finding is not surprising given that these two systems are the 
most often examined neurotransmitters in all types of addiction 
disorders [36, 37]. In case of dopamine, the role of the brain reward 
system is most likely to be involved [38], whereas in case of sero-
tonin, the regulation of behavioral inhibition is most likely to be 
involved [39]. Nevertheless, the available published studies refer 
exclusively to genetic etiological factors, which are also reported in 
other types of addictions.  
 There are, of course, a number of limitations regarding genetic 
studies of human behavior (including those that have specifically 
examined gambling outlined here). Most individual studies have a 
limited sample size, thus restricting statistical power. Replication 
studies are often incapable of reproducing earlier findings. Fur-
thermore, phenotype heterogeneity makes it difficult to compare 
studies with each other and to conduct meta-analyses. Applying 
multiple statistical tests require stringent methods for correction to 
avoid Type 2 errors. Population stratification can further distort 
results of these genetic studies. 
 Although this review has highlighted that genetics can and do 
play an important role in the development of gambling pathology, 
other factors (e.g., individual psychological determinants, environ-
mental and situational factors, structural characteristics of the gam-
bling activity itself, etc.) also have important contributory roles. 
These findings indicate that while genetic predisposition exists, it is 
likely to be a contributing factor rather than being a parsimonious 
explanation. 
 In terms of commonality across all addictive behaviors, includ-
ing both chemical (e.g., alcohol, nicotine, and other drugs) and 
behavioral (e.g., pathological gambling, internet addiction, prob-
lematic video gaming, sex addiction, food and eating disorders, 
etc.), Blum et al. [40] coined the term ‘Reward Deficiency Syn-
drome’ (RDS) to describe an umbrella nomenclature evoking both 
common genetic antecedents and environmental factors explaining 
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addiction in general as a common phenotypy rather than a singular 
specific phenotype. In more recent papers by Blum et al. [41, 42] in 
evaluating two families and five generations, they found that using 
RDS as a generalized phenotype (that included pathological gam-
bling as well as many other behavioral addictions) there were sig-
nificant associations with both the DRD2 and the DAT 1 polymor-
phisms. Specifically, in the genotyped family members, the DRD2 
Taq1 A1 and the DAT1 10/10 alleles were statistically significant 
(at least p<0.015), and more often found in the RDS families than 
when compared to controls. The TaqA1 allele occurred in 100% of 
Family A individuals (N=32) and 47.8% of Family B subjects (11 
of 23). In their original paper [40], the authors used Baysian 
mathematics and found that the predictive value (PV) of carrying 
only the DRD2 Taq1 A1 resulted in a PV of 74.4%. This suggests 
that individuals at birth have a high risk of any addictive behavior 
including pathological gambling in adulthood. This direction of 
further research, under the concept of ‘Reward Deficiency Syn-
drome’, could bring us closer to understanding the common genetic 
background of different chemical and behavioral addictions. Twin 
studies [6] also highlight this finding. It would be especially inter-
esting to identify common factors behind the various addictive be-
haviors but also reveal specific indicators. At the present time it 
appears that while those in the addictions field have relevant 
knowledge about a few common factors, not much is known about 
the indicators that have specific role in the background of a certain 
addictive disorder.  
 It would also be useful for future studies to investigate the dif-
ferent categories of gamblers according to the severity of gambling 
and to analyze whether separate factors can explain the formation 
of the more (or less) severe gambling careers. To date, very few 
empirical research studies have been identified examining the ge-
netic background of problem and pathological gambling. It is hoped 
that further advancement in the gambling studies field will be 
brought about by (i) changes in DSM-V, (ii) advancement of ge-
netic screening technology, and (iii) collaboration of large consortia 
resulting in greater sample sizes and statistical power. 
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